Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 942-330-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442B (Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA)
- Version / remarks:
- adopted July 2010
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted May 2008
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- adopted March 2003
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Reaction products of Fatty acids, tall-oil, compds. with oleylamine and Fatty acids, C18-unsatd., trimers, compds. with oleylamine
- EC Number:
- 942-330-6
- Molecular formula:
- Not applicable (UVCB substance)
- IUPAC Name:
- Reaction products of Fatty acids, tall-oil, compds. with oleylamine and Fatty acids, C18-unsatd., trimers, compds. with oleylamine
- Details on test material:
- - Name of test material (as cited in study report): Reaction mass of Fatty acids, tall-oil, compds. with oleylamine and Fatty acids, C18-unsatd., trimers, compds. with oleylamine
- Physical state: viscous light brown to clear liquid
- Analytical purity: The test item is a complex mixture of isomers and homologues components, so no purity can be stated. (For details see analytical report BASF study-No.: 13L00017)
- Purity test date: Feb.-April 2013
- Lot/batch No.: D987-AM-202011
- Expiration date of the lot/batch: 2013-04-18
- Storage condition of test material: room temperature
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Borchen, Germany
- Age at study initiation: main test: 8 weeks; pretest: 9-12 weeks
- Weight at study initiation: 19.5-21.6g
- Housing: single in Makrolon type II cages
- Diet (e.g. ad libitum): Stanrab (P) SQC, SDS Special Diets Services, ad lib.
- Water (e.g. ad libitum): tab water ad lib.
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 30-70%
- Air changes (per hr): app. 10
- Photoperiod (hrs dark / hrs light): 12h/12h
Study design: in vivo (LLNA)
- Vehicle:
- propylene glycol
- Concentration:
- 0.5%, 1%, 2%
- No. of animals per dose:
- 2 (pre study)
5 (main study) - Details on study design:
- RANGE FINDING TESTS: 3 pre-tests were performed in 6 animals per test (2/concentration) to determine the highest non irritant concentration. Mice were treated with 100%, 50%, 25%, 10%, 5%, and 2.5% (w/w) on three consecutive days.
- Irritation: at 10% and above, mice showed local irritation confirmed by increased ear weights >25%. In addition, concentrations above 25% also led to ear swelling > 25%. Body weight loss >5% was observed at 100%, 50%, and in one animal treated with 25%. Groups 5% also showed increased ear weights >25%, while only one animal treated with 2.5% showed slightly increased ear weight. Thus concentrations of 0.5, 1, and 2% were selected for the main study.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- for better handling, the test substance was heated for app. 10min at 60°C and emulsified in propylene glycol
- 25µL of hand warm preparations were spread over the entire dorsal surface of each ear for three consecutive days
- 4 days after the first administration, 5mg BrdU were i.p. injected per mouse.
- mice were sacrificed after 24h and BrdU incorporation measured using a commercial cell proliferation assay kit (Roche, Mannheim)
- Criteria used to consider a positive response:
At least one concentration of the test item resulted in an incorporation of BrdU at least 1.6-fold or greater than that recorded in control mice, as indicated by the Stimulation Index.
Data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local
toxicity or immunological suppression.
An increase in ear weight exceeding the threshold value of 25% was considered to be indicative for excessive local skin irritation.
For BALB/c mice, a cutoff-value for the lymph node cell count index of 1.55 was reported for a positive response. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- SI = 5.6
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks:
- 0.5 %
- Value:
- 1.6
- Parameter:
- SI
- Remarks:
- 1 %
- Value:
- 1.9
- Parameter:
- SI
- Remarks:
- 2 %
- Value:
- 4
- Cellular proliferation data / Observations:
- The animals did not show any relevant signs of systemic toxicity or excessive signs of local irritation. Stimulation Indices (S.I.) of 1.6, 1.9 and 4.0 were determined with the test item at concentrations of 0.5, 1 and 2% (w/w) in propylene glycol, respectively. Thus the EC1.6 value was equal to the lowest concentration of 0.5% (w/w). A clear dose response was observed.
Any other information on results incl. tables
A statistically significant increase in ear weights was observed in the 1% and 2% group, but remained below the threshold of excessive irritation (increase > 25%). Furthermore, the cut-off-value for a positive response regarding the lymph node cell count index of 1.55 reported for BALB/c mice was exceeded in the mid (1%) and high (2%) dose group and reached statistical significance as well.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
